| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (methicillin-resistant) |
1.667 |
2.667 |
? － ? |
Ceftobiprole (Zeftera) |
942 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
0.25 － 4 |
Oritavancin (LY333328) |
72 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
0.25 － 4 |
Oritavancin (LY333328) |
207 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
≤0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
186 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
109 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
13 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 4 |
Daptomycin (Cubicin) |
16 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
444 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
1 － 8 |
Teicoplanin (Targocid) |
178 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
2 |
? － ? |
Linezolid (PNU-100766, U-100766, Zyvox) |
36 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.03 － >8 |
Moxifloxacin (BAY 12-8039, Avelox) |
207 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.12 － 16 |
Garenoxacin (T-3811, BMS-284756) |
1111 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.125 － 80.25 |
Moxifloxacin (BAY 12-8039, Avelox) |
19 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.25 － 4 |
Amoxicillin-clavulanate |
186 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.25 － 4 |
LBM415 (NVP-PDF-713, VIC-10495) |
207 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.5 － 4 |
BAL9141 |
1111 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
≤0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
475 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.5 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
463 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.5 － 4 |
Ranbezolid (RBX 7644) |
207 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.5 － 4 |
Ranbezolid (RBX 7644) |
72 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
0.5 － >32 |
Linezolid (PNU-100766, U-100766, Zyvox) |
55 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
72 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
1 － 4 |
Trovafloxacin (Trovan) |
244 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
1 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
11 |
| Staphylococcus aureus (methicillin-resistant) |
2 |
4 |
1 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
7 |